Trial Profile
Phase IIB Efficacy and Safety Study of Four Topical Gel Formulations of Anti-Fungal Agents, MQX-5858, MQX-5859, MQX-5866, and MQX-5867, Versus Vehicle in the Treatment of Tinea Unguium.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 May 2014
Price :
$35
*
At a glance
- Drugs Naftifine (Primary) ; Terbinafine (Primary)
- Indications Onychomycosis
- Focus Therapeutic Use
- Sponsors MediQuest Therapeutics
- 22 May 2014 New trial record